Tesla, Solaredge, Palantir, Cleveland-Cliffs, Ocular Therapeutix: Why These 5 Stocks Are Drawing Heavy Attention Today

Zinger Key Points
  • Palantir posted quarterly sales of $508.62 million which beat the analyst consensus estimate of $502.25 million.
  • Solaredge reported quarterly sales of $890.70 million which beat the analyst consensus estimate of $879.23 million.
  • Cleveland-Cliffs recorded a net loss of $204 million for the fourth quarter.

Major Wall Street indices closed over 1% higher on Monday ahead of the release of the consumer price index report on Tuesday. The Nasdaq Composite closed 1.48% higher while the S&P 500 ended the session up 1.14%. The Dow Jones, too, closed 1.11% higher. Meanwhile, the following are the five stocks that are drawing retail investors’ attention:

1. Tesla Inc TSLA: Shares of Tesla closed 1.14% lower on Monday. Analysts have warned the EV company has lagged behind competitors in China in introducing new models, improving navigation systems and bringing in luxe interior touches or white-glove customer service, Reuters reported.

Also Read: Everything You Need To Know About Tesla Stock

2. Palantir Technologies Inc PLTR: Shares of the data analytics software maker closed 1.33% higher and also gained 16.56% in extended trading. The company posted quarterly sales of $508.62 million which beat the analyst consensus estimate of $502.25 million. Palantir reported quarterly earnings of 4 cents per share, which beat the analyst consensus estimate of 3 cents.

3. Solaredge Technologies Inc SEDG: Shares of Solaredge ended 3.33% higher on Monday. The company reported quarterly earnings of $2.86 per share which beat the analyst consensus estimate of $1.55. Solaredge reported quarterly sales of $890.70 million which beat the analyst consensus estimate of $879.23 million.

4. Cleveland-Cliffs Inc. CLF: Shares of the company closed 0.85% higher but ended Monday’s session 3.68% lower. For the fourth quarter of 2022, the company recorded a net loss of $204 million, corresponding to a loss of $0.41 per diluted share as against a net income of $899 million, or $1.69 per diluted share in the same period of the previous quarter.

5. Ocular Therapeutix, Inc. OCUL: Shares of the company closed 35.14% higher on Monday. The company said its OTX-TKI, an axitinib intravitreal hydrogel implant being developed for the treatment of wet age-related macular degeneration, diabetic retinopathy and other retinal diseases, continued to be generally well tolerated with no drug-related serious adverse events through month 10.

Read Next: Palantir CEO Alex Karp Touts Profitability, Artificial Intelligence Advantage, Acquisition Interest Following Q4 Earnings

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsSmall CapTop StoriesMarketsData Analyticselectric vehiclessolar energy
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...